fda warning bpc-157 safety panel narrowly backs unapproved peptide drugs – NBC4 Washington FDA reviews unapproved peptides as

Some common symptoms include low sex drive, fatigue, loss of muscle mass, decreased bone mass, increased body fat, low mood, irritability, high sugar levels, brain fog, high cholesterol and extreme levels of anxiety

Anxiolytic effect of BPC-157, a gastric pentadecapeptide: Shock probe/burying test and light/dark test

Its regenerative properties for muscles, tendons, ligaments, and other soft tissues are promising

Similarly, another long-acting analogue of somatostatin, lanreotide (somatuline), is used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome and VIPomas [34]

Symptom Relief: May reduce abdominal pain, bloating, diarrhea, and discomfort associated with intestinal damage or inflammation